Name: LENZ Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: LENZ, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does LENZ have?

Accepted Answer

LENZ Therapeutics, Inc. (LENZ) has 7 SEC Form 4 filings (15 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Mar 30, 2026.

Question 2

When was the most recent SEC Form 4 filing for LENZ?

Accepted Answer

The most recent Form 4 filing for LENZ on Tracefour is dated Mar 30, 2026.

Question 3

What is the net insider flow at LENZ over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at LENZ have net sold $10.0M based on SEC Form 4 disclosures.

Question 4

What is the total insider buy and sell value at LENZ in the current window?

Accepted Answer

Inside the rolling window, insiders at LENZ bought $655K and sold $10.6M based on SEC Form 4 filings.

Question 5

Can I get alerts for LENZ insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at LENZ Therapeutics, Inc. (LENZ). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
Chevallard Daniel R.First in 5 months	Chief Financial Officer	Purchase	7,500	$64K	Mar 30	SEC ↗
George Jeffrey P.First filing	Director	Purchase	5,592	$50K	Mar 30	SEC ↗
Schimmelpennink Evert B.First filing	President, CEO and Secretary	Purchase	28,089	$251K	Mar 30	SEC ↗
Olsson ShawnFirst filing	Chief Commercial Officer	Sale	10,000	$261K	Nov 19	SEC ↗
MCCOLLUM JAMES WFirst filing	Director	Purchase	10,500	$239K	Nov 10	SEC ↗
Chevallard Daniel R.First filing	Chief Financial Officer	Purchase	2,198	$50K	Nov 7	SEC ↗
Versant Venture Capital VI, L.P.First filing	10% Owner	Sale	224,974	$10.4M	Oct 2	SEC ↗

LENZ

Related companies